Table of Contents
<< Previous Issue | Nov 2004 (Vol: 2004, Issue: 53) | Next Issue >> |
- Section: Business Commentaries
-
Alliances are Forever?
- Section: Company Profile
-
TopoTarget AS
-
Xerion Pharmaceuticals AG
- Section: Deal Trackers
-
Raptiva (efalizumab)
- Section: Distribution & Marketing
-
ISTA and Allergan in New Vitrase® Collaboration
- Section: General
-
Aradigm’s Confidence Boosted by Novo Nordisk
- Section: Licensing
-
Forest Labs Licenses Respiratory Drug from Glenmark
-
Nastech and Merck to Co-Develop Nasal Spray for Obesity
- Section: Mergers & Acquisitions
-
Exelixis to Merge with X-Ceptor Therapeutics
- Section: Research & Development
-
Novartis Validates Xenon and its Obesity Programme with US$157 M Deal
-
Gilead and Genelabs Form Hepatitis C Alliance